Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 182
Selected: 0
NCT IDTitle
NCT01104571Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer
NCT01937533Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer
NCT03145961A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
NCT02389842PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib
NCT01000129Adaptive Planning in Bladder Cancer
NCT02688257Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT00199901Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma
NCT04584853PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
NCT04686188Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
NCT02753569Imaging NSCLC Treatment Response to Immunotherapy
NCT00033683Combination Chemotherapy in Treating Women With Resected Breast Cancer
NCT02193633A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.
NCT05375591AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer
NCT03875820Phase I Trial of Defactinib and VS-6766.
NCT05968417Myeloma Novel Drug Discovery Ver 1.2
NCT03740893PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
NCT02978014A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy
NCT05368298SCOOT: Sample Collection for DART
NCT00261456The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT01331525The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
NCT00077090Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer
NCT01810757Study of Weekly Radiotherapy for Bladder Cancer
NCT02928432SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone
NCT04458311Abiraterone Acetate in Combination With Tildrakizumab
NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
NCT01332968A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
NCT03592550The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
NCT05741801Digital Alerts for Sepsis: a Qualitative Study
NCT06636526The i4i PRODICT™ Study: Evaluation of the i4i PRODICT™ Test in Different Ethnic Groups (The i4i PRODICT™ Study).
NCT02409212Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer
NCT02525068A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC
NCT03466944PUMA (Paediatric Osseous Marrow Assessment)
NCT06975579The COherence of Scatter Identification and Exclusion Algorithm Study
NCT07098819The eValuation of Sources of vIBRAtioN for Vibrational Shear Wave elasTography
NCT01101438A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
NCT02447549Study of Tumour Focused Radiotherapy for Bladder Cancer
NCT01977638Phase 1 Trial of CXD101 in Patients With Advanced Cancer
NCT02543905The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
NCT00028756Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
NCT03946202KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
NCT00031850Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
NCT00107497Radiation Therapy in Treating Women With Localized Breast Cancer
NCT03262311Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours
NCT03307148Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
NCT02819752PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
NCT02560636Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer
NCT02403102Imageguided Theranostics in Multiple Myeloma
NCT00253422Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors
NCT00175838Primary Thrombocythaemia 1 Trial
NCT05840549A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate Enlargement